SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-015765
Filing Date
2023-05-04
Accepted
2023-05-04 16:20:07
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20230331.htm   iXBRL 10-Q 1423746
2 EX-31.1 lyel-20230331x10qxexx311.htm EX-31.1 10748
3 EX-31.2 lyel-20230331x10qxexx312.htm EX-31.2 10718
4 EX-32.1 lyel-20310331x10qxexx321.htm EX-32.1 7591
10 lyel-20230331_g1.jpg GRAPHIC 141479
  Complete submission text file 0001628280-23-015765.txt   6695877

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20230331.xsd EX-101.SCH 43768
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20230331_cal.xml EX-101.CAL 61717
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20230331_def.xml EX-101.DEF 217313
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20230331_lab.xml EX-101.LAB 561443
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20230331_pre.xml EX-101.PRE 366341
54 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20230331_htm.xml XML 970488
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 23889072
SIC: 2834 Pharmaceutical Preparations